4//SEC Filing
Fink Eric 4
Accession 0000899243-20-024184
CIK 0001629137other
Filed
Sep 2, 8:00 PM ET
Accepted
Sep 3, 6:34 PM ET
Size
9.3 KB
Accession
0000899243-20-024184
Insider Transaction Report
Form 4
Fink Eric
Chief Human Resources Officer
Transactions
- Exercise/Conversion
Common Stock
2020-09-01+6,250→ 6,250 total - Exercise/Conversion
Restricted Stock Units
2020-09-01−6,250→ 18,750 total→ Common Stock (6,250 underlying) - Tax Payment
Common Stock
2020-09-01$60.45/sh−1,718$103,853→ 4,532 total
Footnotes (3)
- [F1]Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock.
- [F2]Represents number of shares of Issuer's Common Stock withheld to satisfy the Reporting Person's tax obligations in connection with the vesting of 6,250 shares of Common Stock underlying the Reporting Person's RSUs.
- [F3]The shares of Common Stock underlying the RSUs vested with respect to 1/4th of the shares on September 1, 2020 and thereafter 1/6th of the remaining underlying shares shall vest in semi-annual installments over 3 years from September 1, 2020, so long as the Reporting Person continues as an employee or other service provider of the Issuer through each vesting date. The RSUs are subject to accelerated vesting upon termination without cause or resignation for good reason after a change of control of the Issuer.
Documents
Issuer
Global Blood Therapeutics, Inc.
CIK 0001629137
Entity typeother
Related Parties
1- filerCIK 0001784038
Filing Metadata
- Form type
- 4
- Filed
- Sep 2, 8:00 PM ET
- Accepted
- Sep 3, 6:34 PM ET
- Size
- 9.3 KB